136 related articles for article (PubMed ID: 31841320)
1. Anticoagulant Heparin Mimetics via RAFT Polymerization.
Nahain AA; Ignjatovic V; Monagle P; Tsanaktsidis J; Vamvounis G; Ferro V
Biomacromolecules; 2020 Feb; 21(2):1009-1021. PubMed ID: 31841320
[TBL] [Abstract][Full Text] [Related]
2. Sulfonated RAFT Copolymers as Heparin Mimetics: Synthesis, Reactivity Ratios, and Anticoagulant Activity.
Nahain AA; Ignjatovic V; Monagle P; Tsanaktsidis J; Vamvounis G; Ferro V
Macromol Biosci; 2020 Sep; 20(9):e2000110. PubMed ID: 32627962
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Tumor-Host Cell Interactions Using Synthetic Heparin Mimetics.
Gockel LM; Heyes M; Li H; Al Nahain A; Gorzelanny C; Schlesinger M; Holdenrieder S; Li JP; Ferro V; Bendas G
ACS Appl Mater Interfaces; 2021 Feb; 13(6):7080-7093. PubMed ID: 33533245
[TBL] [Abstract][Full Text] [Related]
4. Neutralase reverses the anti-coagulant but not the anti-thrombotic activity of heparin in a rabbit model of venous thrombosis.
Silver PJ; Broughton R; Bouthillier J; Quinn TA; Wallace AM; Weishaar RE
Thromb Res; 1998 Aug; 91(3):143-50. PubMed ID: 9733158
[TBL] [Abstract][Full Text] [Related]
5. Heparin mimetics with anticoagulant activity.
Nahain AA; Ignjatovic V; Monagle P; Tsanaktsidis J; Ferro V
Med Res Rev; 2018 Sep; 38(5):1582-1613. PubMed ID: 29446104
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant effects and tissue factor pathway inhibitor after intrapulmonary low-molecular-weight heparin.
Harenberg J; Malsch R; Angelescu M; Lange C; Michaelis HC; Wolf H; Heene DL
Blood Coagul Fibrinolysis; 1996 Jun; 7(4):477-83. PubMed ID: 8840001
[TBL] [Abstract][Full Text] [Related]
7. Glycosaminoglycan mimetic biomaterials. 4. Synthesis of sulfated lactose-based glycopolymers that exhibit anticoagulant activity.
Sun XL; Grande D; Baskaran S; Hanson SR; Chaikof EL
Biomacromolecules; 2002; 3(5):1065-70. PubMed ID: 12217054
[TBL] [Abstract][Full Text] [Related]
8. Dendritic polyglycerol sulfates as new heparin analogues and potent inhibitors of the complement system.
Türk H; Haag R; Alban S
Bioconjug Chem; 2004; 15(1):162-7. PubMed ID: 14733596
[TBL] [Abstract][Full Text] [Related]
9. Heparin-like anticoagulant activity of sulphonated poly(ethylene oxide) and sulphonated poly(ethylene oxide)-grafted polyurethane.
Han DK; Lee NY; Park KD; Kim YH; Cho HI; Min BG
Biomaterials; 1995 Apr; 16(6):467-71. PubMed ID: 7654873
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time.
al Dieri R; Alban S; Béguin S; Hemker HC
J Thromb Haemost; 2004 Aug; 2(8):1395-401. PubMed ID: 15304046
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticoagulant activity of polyureas containing sulfated carbohydrates.
Huang Y; Shaw MA; Mullins ES; Kirley TL; Ayres N
Biomacromolecules; 2014 Dec; 15(12):4455-66. PubMed ID: 25329742
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
Wang ZM; Li L; Li B; Guo SY
Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of the anticoagulant properties of a range of structurally diverse sulfated oligosaccharides.
Wall D; Douglas S; Ferro V; Cowden W; Parish C
Thromb Res; 2001 Aug; 103(4):325-35. PubMed ID: 11562342
[TBL] [Abstract][Full Text] [Related]
14. Heparin-like anticoagulant polypeptides with tunable activity: Synthesis, characterization, anticoagulative properties and clot solubilities in vitro.
Lu D; Jin Y; Wang X; Xie L; Liu Q; Chen Y; Wang H; Lei Z
Mater Sci Eng C Mater Biol Appl; 2021 Oct; 129():112405. PubMed ID: 34579917
[TBL] [Abstract][Full Text] [Related]
15. The APTT response of pregnant plasma to unfractionated heparin.
Chunilal SD; Young E; Johnston MA; Robertson C; Naguit I; Stevens P; Galashan D; Oskamp ML; Brennan B; Ginsberg JS
Thromb Haemost; 2002 Jan; 87(1):92-7. PubMed ID: 11848463
[TBL] [Abstract][Full Text] [Related]
16. Influence of different anticoagulant agents on fibrinopeptide a generation.
Tobu M; Iqbal O; Messmore HL; Ma Q; Hoppensteadt DA; Fareed J
Clin Appl Thromb Hemost; 2003 Oct; 9(4):273-92. PubMed ID: 14653437
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant properties of a sulfated galactan preparation from a marine green alga, Codium cylindricum.
Matsubara K; Matsuura Y; Bacic A; Liao M; Hori K; Miyazawa K
Int J Biol Macromol; 2001 Jun; 28(5):395-9. PubMed ID: 11325427
[TBL] [Abstract][Full Text] [Related]
18. The limited importance of factor Xa inhibition to the anticoagulant property of heparin in thromboplastin-activated plasma.
Pieters J; Lindhout T
Blood; 1988 Dec; 72(6):2048-52. PubMed ID: 3196877
[TBL] [Abstract][Full Text] [Related]
19. Sulfated sericin is a novel anticoagulant influencing the blood coagulation cascade.
Sano M; Tamada Y; Niwa K; Morita T; Yoshino G
J Biomater Sci Polym Ed; 2009; 20(5-6):773-83. PubMed ID: 19323889
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulant and antiprotease activities of a heparinoid sulfated glucoside-bearing polymer.
Onishi M; Miyashita Y; Motomura T; Yamashita S; Sakamoto N; Akashi M
J Biomater Sci Polym Ed; 1998; 9(9):973-84. PubMed ID: 9747989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
